These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3519043)

  • 1. Acute effects of increasing doses of urapidil in patients with hypertension.
    Culbertson VL; Bryant PJ; Cady WJ; Rubison RM; Piepho RW; Nies AS; Byyny RL
    Clin Pharmacol Ther; 1986 Jun; 39(6):690-6. PubMed ID: 3519043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of urapidil and atenolol in hypertension.
    Török E; Wagner M; Podmaniczky M
    Drugs; 1988; 35 Suppl 6():164-72. PubMed ID: 3042356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
    Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
    Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
    Stumpe KO; Feldhaus P; Haerlin R
    Fortschr Med; 1989 Jan; 107(1):54-7. PubMed ID: 2646188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y
    Drugs; 1988; 35 Suppl 6():156-63. PubMed ID: 3042355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic assessment of urapidil or angiotensin-converting enzyme inhibition in systemic hypertension.
    Rosenthal J; Haerlin R
    Am J Cardiol; 1989 Aug; 64(7):25D-29D. PubMed ID: 2667311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of urapidil in the management of essential hypertension. A comparison with captopril.
    Rosenthal J; Haerlin R; Schäfer N; Christ B; Wurst W
    Drugs; 1988; 35 Suppl 6():147-55. PubMed ID: 3042354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.
    van der Stroom JG; van Wezel HB; Langemeijer JJ; Korsten HH; Kooyman J; van der Starre PJ; Kal JE; Porsius M; van den Ende R; van Zwieten PA
    J Cardiothorac Vasc Anesth; 1997 Oct; 11(6):729-36. PubMed ID: 9327314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.
    Distler A; Haerlin R; Hilgenstock G; Passfall J
    Drugs; 1990; 40 Suppl 4():21-7; discussion 28-30. PubMed ID: 2092965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
    Oberman A; Pool PE
    Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C; Barros LM; Batlouni M; Sousa JE
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mild hypertension with urapidil or captopril.
    Rosenthal J; Schäfer N; Haerlin R; Wurst W; Solleder P
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):233S-236S. PubMed ID: 3046630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
    Leonetti G; Mazzola C; Boni S; Guffanti E; Meani A; Zanchetti A
    Eur J Clin Pharmacol; 1986; 30(6):637-40. PubMed ID: 3533561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute responses to urapidil in hypertensive persons.
    de Leeuw PW; Birkenhäger WH
    Am J Cardiol; 1989 Aug; 64(7):22D-24D. PubMed ID: 2667310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.
    Taniguchi K; Nakamura S; Iesaka Y; Nitta M; Ito H; Kirigaya H; Takeuchi J; Fujiwara H; Iizumi T; Inada M
    Clin Ther; 1985; 7(5):559-67. PubMed ID: 4053145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.
    Rosenthal J; Haerlin R
    J Hypertens Suppl; 1988 Dec; 6(2):S69-71. PubMed ID: 3068344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravenous terazosin in hypertensive patients. A preliminary report.
    Cohen A
    Am J Med; 1986 May; 80(5B):86-93. PubMed ID: 2872814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indenolol in hypertension.
    Sega R; Mailland F; Damiani E; Groothold G; Libretti A
    Clin Pharmacol Ther; 1983 Mar; 33(3):289-93. PubMed ID: 6337761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.